Ann Lab Med.  2023 Nov;43(6):625-627. 10.3343/alm.2023.43.6.625.

No Observed Interference by Nucleated Red Blood Cells in Total Bilirubin Measurement by Point-of-Care Testing: Six Years of Experience

• Chávez EM
• Oliver P
• Buño A
• Fernández-Calle P

• KMID: 2552041
• DOI: http://doi.org/10.3343/alm.2023.43.6.625

Figure

• 

  Fig. 1 Workflow of the study. *Biological reference interval in newborns: 0–10/100 WBC; †First measurement. Abbreviations: DBil, direct bilirubin; DifHr, difference between blood collections (in hours); DifTBil, TBil concentration difference; LAB, laboratory; TBil, total bilirubin; POCT, point-of-care testing; NRBC, nucleated red blood cells; WBC, white blood cells.

Reference

1. Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, et al. 2022; Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 150:e2022058859. DOI: 10.1542/peds.2022-058859. PMID: 35927462.

2. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. 2012; An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 32:660–4. DOI: 10.1038/jp.2012.71. PMID: 22678141.

3. Colombo G, Szoke D, Aloisio E, Cavigioli F, Dolci A, Panteghini M. 2022; Clinicians at crossroads for a dangerous interference in neonatal bilirubin determination at the point-of-care. Clin Chem. 68:887–91. DOI: 10.1093/clinchem/hvac077. PMID: 35780507.

4. Lo S. 2022; Commentary on clinicians at crossroads for a dangerous interference in neonatal bilirubin determination at the point-of-care. Clin Chem. 68:891. DOI: 10.1093/clinchem/hvac078. PMID: 35780506.

5. Wojcik MH. 2022; Commentary on clinicians at crossroads for a dangerous interference in neonatal bilirubin determination at the point-of-care. Clin Chem. 68:892. DOI: 10.1093/clinchem/hvac080. PMID: 35780509.